Age-Related Macular Degeneration Treatment Drugs Market to Reach US$90 bn by 2020

The report analyzes the historical as well as the current performance of this market, highlighting the major market trends.

The research report is titled “China, India, US And Japan Drugs For Treatment Of Age-Related Macular Degeneration Research Report To 2020.”

According to this study, the global market for age-related macular degeneration treatment drugs is estimated to rise at a CAGR of 6.78% during the period from 2016 to 2021 and increase from US$64.83 bn in 2015 to US$90 bn by the end of the forecast period.

The rapid increase in the global geriatric population is the key driving force behind the rise of the worldwide age-related macular degeneration treatment drugs market. In the U.S., the revenue generated from the sale of these drugs reached US$36.8 bn in 2015, notes the study.

This 122-page research report, aided by 152 charts, offers a comprehensive study of the worldwide market for age-related macular degeneration treatment drugs. It examines the driving forces, restraints, and opportunities influencing the market’s trajectory in detail. It also presents a descriptive study of the current and forthcoming major market challenges to help participants understand the issues they may face while operating in this market in the long run.

The global market for age-related macular degeneration treatment drugs has been segmented on the basis of the type of product and geography in this research report. Based on the type of product, the market has been classified into conbercept ophthalmic injection, avastin, eylea, pegaptanib, lucentis, verteporfin powder for injection, and augentropfen stulln mono. By region, the research studies factors influencing growth of the age-related macular degeneration treatment drugs market in China, India, Japan, and the U.S.

The competitive landscape of the global age-related macular degeneration treatment drugs market has also been thoroughly studied in this research report. The major market participants are analyzed to determine the existing market hierarchy. As per the report, Pharma Stulln GmbH, Pfizer, Bayer, Chengdu Kanghong Biotechnologies, Novartis Pharma, Regeneron, and Eyetech are the leading manufacturers of age-related macular degeneration treatment drugs across the world.

Get free sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/740151

In conclusion, the research study discusses the existing as well as the upcoming ventures and projects in the global market for age-related macular degeneration treatment drugs at length. Information included in this research report makes it of special value for enterprises and consultants operational in this industry. The rise in investments to increase research activities for the advancement of age-related macular degeneration treatment drugs is projected to drive this market during the forecast period, states the research report.

Marketresearchreports.biz is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profiles in its repository. We also offer consulting support for custom market research needs.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz
Email: sales@marketresearchreports.biz

This release was published on openPR.